| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fc6c2e9e63b6561f2f46b1de31f6379 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-28 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60 |
| filingDate |
2003-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2006-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1ebd2faa216cfcc3742b225d7556b2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3844011cfbd165a1eec6a6f24915ed1 |
| publicationDate |
2006-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7135197-B2 |
| titleOfInvention |
Stable pharmaceutical composition useful for treating gastrointestinal disorders |
| abstract |
The present invention provides a pharmaceutical composition comprising at least one pharmaceutically acceptable bismuth-containing compound, at least one pharmaceutically acceptable non-clay-derived suspending agent, and water. The suspension exhibits reduced upward pH drift by comparison with an otherwise similar suspension which comprises a clay-derived suspending agent. Such compositions are useful in the prevention and treatment of gastrointestinal diseases and/or disorders. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008132941-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009028920-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014094424-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10632200-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009028914-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018190658-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8883190-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9486460-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10034888-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9486436-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8668703-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10039835-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008133027-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8883183-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10532063-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-038764-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9131686-B2 |
| priorityDate |
2002-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |